These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31150659)

  • 1. Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics.
    de Leon J
    Neuropharmacology; 2020 May; 168():107656. PubMed ID: 31150659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone.
    Schoretsanitis G; Spina E; Hiemke C; de Leon J
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1237-1253. PubMed ID: 30449206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone.
    Schoretsanitis G; Spina E; Hiemke C; de Leon J
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):965-981. PubMed ID: 28699847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision psychiatry: The complexity of personalizing antipsychotic dosing.
    de Leon J
    Eur Neuropsychopharmacol; 2022 May; 58():80-85. PubMed ID: 35314415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone.
    Schoretsanitis G; Spina E; Hiemke C; de Leon J
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):625-639. PubMed ID: 29776316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using therapeutic drug monitoring to personalize clozapine dosing in Asians.
    de Leon J; Schoretsanitis G; Kane JM; Ruan CJ
    Asia Pac Psychiatry; 2020 Jun; 12(2):e12384. PubMed ID: 32119764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data.
    Samtani MN; Gopal S; Gassmann-Mayer C; Alphs L; Palumbo JM
    CNS Drugs; 2011 Oct; 25(10):829-45. PubMed ID: 21936586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Ageing on Serum Concentrations of Risperidone and Its Active Metabolite in Patients with Known CYP2D6 Genotype.
    Molden E; Waade RB; Hoff M; Haslemo T
    Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):470-475. PubMed ID: 27145399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations-an observational study using blood samples from 1223 patients.
    Tveito M; Høiseth G; Haslemo T; Molden E; Smith RL
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1201-1208. PubMed ID: 33616704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.
    Scordo MG; Spina E; Facciolà G; Avenoso A; Johansson I; Dahl ML
    Psychopharmacology (Berl); 1999 Dec; 147(3):300-5. PubMed ID: 10639689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
    Am J Psychiatry; 2020 Apr; 177(4):342-353. PubMed ID: 31838873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paliperidone palmitate for schizophrenia.
    Nussbaum AM; Stroup TS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD008296. PubMed ID: 22696377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    Asian J Psychiatr; 2018 Jun; 35():28. PubMed ID: 29751217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Int Clin Psychopharmacol; 2020 May; 35(3):163-169. PubMed ID: 31851035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service.
    Castberg I; Spigset O
    Ther Drug Monit; 2005 Feb; 27(1):103-6. PubMed ID: 15665755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations.
    Russu A; Kern Sliwa J; Ravenstijn P; Singh A; Mathews M; Kim E; Gopal S
    Int J Clin Pract; 2018 Jun; 72(6):e13089. PubMed ID: 29707876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series].
    Kalenderoğlu A; Çelik M
    Turk Psikiyatri Derg; 2016; 27(1):57-62. PubMed ID: 27369686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.